Cas no 537-42-8 (Pterostilbene)
Pterostilbene Chemical and Physical Properties
Names and Identifiers
-
- 4-(3,5-Dimethoxystyryl)phenol
- AKOS 236-80
- 3,5-DIMETHOXY-4'-HYDROXYSTILBENE
- 3',5'-DIMETHOXY-4-STILBENOL
- 4-[(1E)-2-(3,5-DIMETHOXYPHENYL)ETHENYL]PHENOL
- PTEROSTILBENE
- PTEROCARPUS MARSUPIUM
- TRANS-3,5-DIMETHOXY-4'-HYDROXYSTILBENE
- (E)-3,5-Dimethoxy-4'-hydroxystilbene
- (E)-4-(3,5-Dimethoxystyryl)phenol
- 4-[(E)-2-(3,5-dimethoxyphenyl)ethenyl]phenol
- 4-[(E)-2-(3,5-Dimethoxyphenyl)vinyl]phenol
- PTEROSTILBENE(P) PrintBack
- 3,5-Dimethoxy-4'-hydroxy-trans-stilbene
- 4'-hydroxy-3,5-dimethoxystilbene
- 4'-Hydroxy-3,5-dimethoxy-trans-stilbene
- Pterostilbene,Pterocarpus marsupium
- trans-1-(3,5-Dimethoxyphenyl)-2-(4-hydroxyphenyl)ethylene
- 3,5-Dimethoxy-4′-hydroxystilbene
- Rosewood
- trans-pterostilbene
- pterostilben
- VLEUZFDZJKSGMX-ONEGZZNKSA-N
- 4-((E)-2-(3,5-dimethoxyphenyl)ethenyl)phenol
- 26R60S6A5I
- Pterostilbene, Pte
- Pterostilbene,99%
- (E)-1-hydroxy-4-(3,5-dimethoxy)styrylbenzene
- trans-4-Hydroxy 3',5'-dimethoxystilbene
- 4-(2-(3,5-Dimethoxyphenyl)ethenyl)phenol
- 3',5'-dimethoxy-resveratrol
- SMR000440694
- MLS000863581
- MLS001424135
- MLS000759434
- ConMedNP.439
- (E)-3',5'-dimethoxy-4-stilbenol
- (E)-4'-hydroxy-3,5-dimethoxystilbene
- MLSMR
- Pterostilbene
-
- MDL： MFCD00238710
- Inchi： 1S/C16H16O3/c1-18-15-9-13(10-16(11-15)19-2)4-3-12-5-7-14(17)8-6-12/h3-11,17H,1-2H3/b4-3+
- InChI Key： VLEUZFDZJKSGMX-ONEGZZNKSA-N
- SMILES： O(C([H])([H])[H])C1C([H])=C(C([H])=C(/C(/[H])=C(\[H])/C2C([H])=C([H])C(=C([H])C=2[H])O[H])C=1[H])OC([H])([H])[H]
- BRN： 6(4)7592
Computed Properties
- Exact Mass: 256.11000
- Monoisotopic Mass: 256.109944368 g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 19
- Rotatable Bond Count: 4
- Complexity: 270
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 1
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 38.7
- Topological Polar Surface Area: 38.7A^2
- Isotope Atom Count: 0
- Molecular Weight: 256.30
- XLogP3: 3.8
Experimental Properties
- Color/Form: Gray white crystalline powder
- Density: 1.1690
- Melting Point: 89-92 oC
- Boiling Point: 420.4℃ at 760 mmHg
- Flash Point: 208.1±25.9 °C
- Refractive Index: 1.639
- Solubility: DMSO: >20mg/mL
- PSA: 38.69000
- LogP: 3.57980
- λmax: 321(MeOH)(lit.)
- FEMA: 3394
- Sensitiveness: Sensitive to light
Pterostilbene Security Information
-
Symbol:
- Signal Word：Danger
- Hazard Statement： H318,H411
- Warning Statement： P273,P280,P305+P351+P338
- Hazardous Material transportation number：UN 3077
- WGK Germany：3
- Hazard Category Code： 41-51/53
- Safety Instruction： S26-S39-S61
-
Hazardous Material Identification：
- HazardClass：IRRITANT
- PackingGroup：Ⅲ
- Storage Condition：2-8°C
- Risk Phrases：R41; R51/53
Pterostilbene Customs Data
- Customs Data：
China Customs Code:
2909500000Overview:
2909500000. Ether phenol\Ether alcohol phenol and its halogenation\sulfonation\Nitrosative or nitrosative derivatives. VAT:17.0%. Tax refund rate:9.0%. Regulatory conditions:nothing. MFN tariff:5.5%. general tariff:30.0%
Declaration elements:
Product Name, component content, use to
Summary:
2909500000 ether-phenols, ether-alcohol-phenols and their halogenated, sulphonated, nitrated or nitrosated derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0%
Pterostilbene Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | PHL83261-10MG |
Pterostilbene |
537-42-8 | 10mg |
￥2923.97 | 2024-12-26 | ||
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | P1924-1G |
Pterostilbene |
537-42-8 | >98.0%(HPLC) | 1g |
￥5440.00 | 2023-09-07 | |
| Fluorochem | 093412-1g |
4-(3,5-Dimethoxystyryl)phenol |
537-42-8 | 98% | 1g |
￡10.00 | 2022-03-01 | |
| Fluorochem | 093412-5g |
4-(3,5-Dimethoxystyryl)phenol |
537-42-8 | 98% | 5g |
￡26.00 | 2022-03-01 | |
| Fluorochem | 093412-10g |
4-(3,5-Dimethoxystyryl)phenol |
537-42-8 | 98% | 10g |
￡45.00 | 2022-03-01 | |
| Fluorochem | 093412-25g |
4-(3,5-Dimethoxystyryl)phenol |
537-42-8 | 98% | 25g |
￡80.00 | 2022-03-01 | |
| TRC | P839890-50mg |
Pterostilbene |
537-42-8 | 50mg |
$ 71.00 | 2023-09-06 | ||
| TRC | P839890-100mg |
Pterostilbene |
537-42-8 | 100mg |
$127.00 | 2023-05-17 | ||
| TRC | P839890-250mg |
Pterostilbene |
537-42-8 | 250mg |
$253.00 | 2023-05-17 | ||
| TRC | P839890-1g |
Pterostilbene |
537-42-8 | 1g |
$ 356.00 | 2023-09-06 |
Pterostilbene Suppliers
Audited Supplier
Audited Supplier
Pterostilbene Related Literature
-
2. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
-
Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
-
Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
Additional information on Pterostilbene
Pterostilbene (CAS No. 537-42-8): A Promising Compound in the Field of Chemoprevention and Neuroprotection
Pterostilbene, a natural compound with the chemical formula C16H12O3, is a stilbenoid that has garnered significant attention in recent years due to its potential health benefits. With the CAS number 537-42-8, this compound is primarily found in blueberries, grapes, and certain other fruits. Its structural similarity to resveratrol, another well-known stilbenoid, has led to extensive research into its biological activities and therapeutic applications.
Pterostilbene has been extensively studied for its antioxidant, anti-inflammatory, and anticancer properties. Recent studies have highlighted its potential in preventing and treating various diseases, including cardiovascular disorders, diabetes, and neurodegenerative conditions. One of the key mechanisms through which Pterostilbene exerts its beneficial effects is by modulating cellular signaling pathways and gene expression.
In the context of chemoprevention, Pterostilbene has shown promising results in inhibiting the growth of cancer cells. Research published in the journal Cancer Prevention Research demonstrated that Pterostilbene can induce apoptosis (programmed cell death) in cancer cells while sparing normal cells. This selective cytotoxicity makes it a potential candidate for cancer therapy. Additionally, studies have shown that Pterostilbene can inhibit angiogenesis, the formation of new blood vessels that supply nutrients to tumors, thereby limiting tumor growth and metastasis.
Beyond its anticancer properties, Pterostilbene has also been investigated for its role in managing metabolic disorders. A study published in the journal Molecular Nutrition & Food Research found that Pterostilbene can improve insulin sensitivity and reduce blood glucose levels in diabetic animal models. These findings suggest that Pterostilbene may be a valuable adjunct therapy for managing type 2 diabetes and related complications.
In the realm of neuroprotection, Pterostilbene has shown significant promise. Research published in the journal Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease indicated that Pterostilbene can protect neurons from oxidative stress and inflammation, which are key factors in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The compound's ability to cross the blood-brain barrier further enhances its therapeutic potential in these conditions.
The bioavailability of Pterostilbene is another important aspect that has been studied extensively. Unlike resveratrol, which has poor bioavailability due to rapid metabolism and excretion, Pterostilbene exhibits higher bioavailability and longer-lasting effects. This makes it a more attractive candidate for therapeutic applications. A study published in the journal The Journal of Pharmacology and Experimental Therapeutics reported that oral administration of Pterostilbene leads to significant plasma levels and sustained biological activity.
Clinical trials are currently underway to further evaluate the safety and efficacy of Pterostilbene. Preliminary results from a phase I clinical trial published in the journal Clinical Cancer Research showed that oral administration of Pterostilbene was well-tolerated by patients with advanced solid tumors. The trial also provided preliminary evidence of antitumor activity, warranting further investigation.
In conclusion, Pterostilbene (CAS No. 537-42-8) is a multifaceted compound with a wide range of potential health benefits. Its antioxidant, anti-inflammatory, anticancer, and neuroprotective properties make it a promising candidate for various therapeutic applications. Ongoing research continues to uncover new mechanisms and potential uses for this natural compound, highlighting its significance in the field of chemoprevention and neuroprotection.
537-42-8 (Pterostilbene) Related Products
- 63844-75-7(Benzene, 1,3-dimethoxy-5-[2-(4-methoxyphenyl)ethenyl]-)
- 21956-56-9(trans-3,5-Dimethoxystilbene)
- 42438-89-1(Pinostilbene)
- 441351-32-2((Z)-Pterostilbene)
- 33626-08-3(4'-Methoxyresveratrol)
- 22255-22-7(trans-Trimethoxyresveratrol)
- 35302-70-6(Pinosylvin monomethyl ether)
- 220862-05-5(3-[(E)-2-(3-Hydroxyphenyl)vinyl]-5-methoxyphenol)
- 18259-15-9(Phenol,4-[2-(3,5-dimethoxyphenyl)ethenyl]-)
- 21956-55-8(Benzene, 1,3-dimethoxy-5-(2-phenylethenyl)-, (Z)-)
